Published in Endocr Relat Cancer on April 10, 2012
Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. J Clin Oncol (2013) 1.52
Hormonal therapies in young breast cancer patients: when, what and for how long? J Thorac Dis (2013) 0.94
Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles. Mol Hum Reprod (2014) 0.81
Gonadal function and reproductive health in women with human immunodeficiency virus infection. Endocrinol Metab Clin North Am (2014) 0.75
Incidence of chemotherapy-induced amenorrhea after adjuvant chemotherapy with taxane and anthracyclines in young patients with breast cancer. Iran J Cancer Prev (2013) 0.75
Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram. Oncologist (2015) 0.75
Chemotherapy-induced amenorrhea in patients suffering from breast cancer in the Northwest of Iran. South Asian J Cancer (2014) 0.75
Regressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone. Sci Pharm (2017) 0.75
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys (2010) 2.66
Twenty years of radiobiology in clinical practice: the Italian contribution. Tumori (2015) 1.98
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.68
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys (2012) 1.60
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. Nat Rev Clin Oncol (2009) 1.55
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest (2009) 1.51
Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys (2013) 1.45
Endocrine side effects induced by immune checkpoint inhibitors. J Clin Endocrinol Metab (2013) 1.42
Triazene compounds: mechanism of action and related DNA repair systems. Pharmacol Res (2007) 1.36
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro. Int J Cancer (2003) 1.10
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2009) 1.05
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. Oncologist (2012) 0.99
Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer. J Exp Clin Cancer Res (2013) 0.99
CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid (2005) 0.97
Circulating tumor cells in colorectal cancer patients. Cancer Treat Rev (2013) 0.96
Endocrinological side-effects of immune checkpoint inhibitors. Curr Opin Oncol (2016) 0.96
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. Int J Radiat Oncol Biol Phys (2012) 0.94
IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique. J Exp Clin Cancer Res (2011) 0.93
A feasibility dosimetric study on prostate cancer : are we ready for a multicenter clinical trial on SBRT? Strahlenther Onkol (2015) 0.91
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur J Endocrinol (2013) 0.90
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy. J Nucl Med (2015) 0.89
Drug-induced increase of carcinoembryonic antigen expression in cancer cells. Pharmacol Res (2004) 0.89
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens (2015) 0.88
Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years. J Exp Clin Cancer Res (2010) 0.87
Ultrasound features of medullary thyroid carcinoma correlate with cancer aggressiveness: a retrospective multicenter study. J Exp Clin Cancer Res (2014) 0.84
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. BMC Cancer (2011) 0.84
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes. J Exp Clin Cancer Res (2013) 0.83
Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial. Int J Radiat Oncol Biol Phys (2008) 0.83
Video-assisted minimally invasive parathyroidectomy: benefits and long-term results. World J Surg (2009) 0.83
Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma. Radiat Oncol (2012) 0.82
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors. Theor Biol Med Model (2012) 0.82
Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer. Head Neck (2011) 0.82
Implementation of a new cost efficacy method for blood irradiation using a non dedicated device. J Exp Clin Cancer Res (2011) 0.82
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy. J Exp Clin Cancer Res (2008) 0.82
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging (2013) 0.82
Radiation protection measurements around a 12 MeV mobile dedicated IORT accelerator. Med Phys (2010) 0.81
Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT. Eur J Radiol (2011) 0.81
Modeling the positioning of single needle electrodes for the treatment of breast cancer in a clinical case. Biomed Eng Online (2015) 0.81
Thyroid dysfunction as an unintended side effect of anticancer drugs. Thyroid (2013) 0.80
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). Cancer Chemother Pharmacol (2013) 0.80
Serum p53 antibody detection in patients with impaired lung function. BMC Cancer (2013) 0.80
Patient positioning in the proton radiotherapy era. J Exp Clin Cancer Res (2010) 0.80
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors? Thyroid (2009) 0.79
Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control. J Exp Clin Cancer Res (2013) 0.79
The role of adrenal scintigraphy in the diagnosis of subclinical Cushing's syndrome and the prediction of post-surgical hypoadrenalism. World J Surg (2014) 0.79
Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound. J Exp Clin Cancer Res (2013) 0.79
Preliminary results of 45 patients with trigeminal neuralgia treated with radiosurgery compared to hypofractionated stereotactic radiotherapy, using a dedicated linear accelerator. J Clin Neurosci (2012) 0.78
Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma. J Exp Clin Cancer Res (2010) 0.78
Tissue heterogeneity in IMRT dose calculation for lung cancer. Med Dosim (2010) 0.78
Potential third-party radiation exposure from patients undergoing therapy with 131I for thyroid cancer or metastases. Health Phys (2015) 0.78
In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta=1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys (2013) 0.78
Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer. Radiat Oncol (2011) 0.78
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro. Anticancer Res (2004) 0.78
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature. BMC Endocr Disord (2014) 0.78
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail. Eur J Nucl Med Mol Imaging (2012) 0.77
Monitoring of people and workers exposure to the electric, magnetic and electromagnetic fields in an Italian National Cancer Institute. J Exp Clin Cancer Res (2008) 0.77
Hypofractionated Conformal Radiotherapy (HCRT) for primary and metastatic lung cancers with small dimension : efficacy and toxicity. Strahlenther Onkol (2009) 0.77
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies. Anticancer Res (2010) 0.76
SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation. J Exp Clin Cancer Res (2012) 0.76
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control. Cancer Med (2014) 0.76
Combined effects of protein kinase inhibitors and 5-fluorouracil on CEA expression in human colon cancer cells. Pharmacol Res (2005) 0.76
Real-world study of everolimus in advanced progressive neuroendocrine tumors. Oncologist (2015) 0.76
Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. J Clin Endocrinol Metab (2007) 0.76
Dose evaluation for skin and organ in hepatocellular carcinoma during angiographic procedure. J Exp Clin Cancer Res (2013) 0.75
Development and optimization of a beam shaper device for a mobile dedicated IOERT accelerator. Med Phys (2012) 0.75
"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging. Endocrine (2013) 0.75
Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. Am J Clin Oncol (2011) 0.75
Pharmacological modulation of carcinoembryonic antigen in human cancer cells: studies with staurosporine. Int Immunopharmacol (2002) 0.75
Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer. J Appl Clin Med Phys (2013) 0.75
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate. Anticancer Drugs (2017) 0.75
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details. J Nucl Med (2017) 0.75
Characterization of a cable-free system based on p-type MOSFET detectors for "in vivo" entrance skin dose measurements in interventional radiology. Med Phys (2012) 0.75
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient. Anticancer Drugs (2017) 0.75
Early diagnosis by FNA cytology should not influence the outcome of differentiated thyroid cancer. Endocr J (2016) 0.75
A Rare Case of Lateral Ectopic Thyroid. Clin Nucl Med (2016) 0.75
A rare case of neuroendocrine tumor of the middle ear detected by gallium-68-DOTANOC-PET/CT. J Clin Endocrinol Metab (2013) 0.75